Clinical Trials in Arizona

Showing 9261-9280 of 16,770 trials

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

NCT02048384

This is a phase 1b, multi-center, open label, randomized study to evaluate the safety and feasibility of administering metformin with or without rapamycin after disease stabilization on chemotherapy in subjects with metastatic PDA.

Metastatic Pancreatic Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins22 participantsStarted Jun 2014

Scottsdale, Arizona, United States • Baltimore, Maryland, United States

COMPLETEDPhase 131 miles

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

NCT02501902

This is a Phase 1, open label, multi center, multiple dose, dose escalation, safety, pharmacokinetic and pharmacodynamic study of palbociclib in combination with nab-P, in sequential cohorts of adult patients with mPDAC, with MTD expansion cohort(s). Approximately 30-60 patients are expected to be enrolled in the overall study.

Metastatic Pancreatic Ductal Adenocarcinoma

Pfizer76 participantsStarted Nov 2015

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +23 more locations

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Find Trials by Condition in Arizona

A Phase II Study of M2951 in SLE

A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist

Essure (Model ESS310) Placement Rate Study

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

Study of CAD-1883 for Spinocerebellar Ataxia

Rheos System for the Treatment of HFpEF Heart Failure

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS

A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects